CMS encouraging Part D sponsors to help with pharmacy eRx costs
Executive Summary
CMS is asking Medicare Part D prescription drug plan sponsors to review agreements they have with pharmacy networks to ensure that dispensing fees help address electronic prescription costs. "We believe that it is unlikely that dispensing fees that were negotiated prior to a pharmacy's implementation of e-prescribing factored into these costs," the agency said in a Sept. 19 memo to sponsors. "Therefore, we would expect Part D sponsors to review network dispensing fees to ensure they appropriately reimburse pharmacies for these new costs." The agency also suggested that Part D sponsors could help to spur e-prescribing at the pharmacy level by making an incentive payment to pharmacies that process e-prescriptions and report those amounts as additional dispensing fees
You may also be interested in...
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.
Xaira Launches With $1bn-Plus And End-To-End AI Strategy
ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.